Cargando…

Rational Design and Characterization of D-Phe-Pro-D-Arg-Derived Direct Thrombin Inhibitors

The tremendous social and economic impact of thrombotic disorders, together with the considerable risks associated to the currently available therapies, prompt for the development of more efficient and safer anticoagulants. Novel peptide-based thrombin inhibitors were identified using in silico stru...

Descripción completa

Detalles Bibliográficos
Autores principales: Figueiredo, Ana C., Clement, Cristina C., Zakia, Sheuli, Gingold, Julian, Philipp, Manfred, Pereira, Pedro J. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311629/
https://www.ncbi.nlm.nih.gov/pubmed/22457833
http://dx.doi.org/10.1371/journal.pone.0034354
_version_ 1782227798489825280
author Figueiredo, Ana C.
Clement, Cristina C.
Zakia, Sheuli
Gingold, Julian
Philipp, Manfred
Pereira, Pedro J. B.
author_facet Figueiredo, Ana C.
Clement, Cristina C.
Zakia, Sheuli
Gingold, Julian
Philipp, Manfred
Pereira, Pedro J. B.
author_sort Figueiredo, Ana C.
collection PubMed
description The tremendous social and economic impact of thrombotic disorders, together with the considerable risks associated to the currently available therapies, prompt for the development of more efficient and safer anticoagulants. Novel peptide-based thrombin inhibitors were identified using in silico structure-based design and further validated in vitro. The best candidate compounds contained both l- and d-amino acids, with the general sequence d-Phe(P3)-Pro(P2)-d-Arg(P1)-P1′-CONH(2). The P1′ position was scanned with l- and d-isomers of natural or unnatural amino acids, covering the major chemical classes. The most potent non-covalent and proteolysis-resistant inhibitors contain small hydrophobic or polar amino acids (Gly, Ala, Ser, Cys, Thr) at the P1′ position. The lead tetrapeptide, d-Phe-Pro-d-Arg-d-Thr-CONH(2), competitively inhibits α-thrombin's cleavage of the S2238 chromogenic substrate with a K(i) of 0.92 µM. In order to understand the molecular details of their inhibitory action, the three-dimensional structure of three peptides (with P1′ l-isoleucine (fPrI), l-cysteine (fPrC) or d-threonine (fPrt)) in complex with human α-thrombin were determined by X-ray crystallography. All the inhibitors bind in a substrate-like orientation to the active site of the enzyme. The contacts established between the d-Arg residue in position P1 and thrombin are similar to those observed for the l-isomer in other substrates and inhibitors. However, fPrC and fPrt disrupt the active site His57-Ser195 hydrogen bond, while the combination of a P1 d-Arg and a bulkier P1′ residue in fPrI induce an unfavorable geometry for the nucleophilic attack of the scissile bond by the catalytic serine. The experimental models explain the observed relative potency of the inhibitors, as well as their stability to proteolysis. Moreover, the newly identified direct thrombin inhibitors provide a novel pharmacophore platform for developing antithrombotic agents by exploring the conformational constrains imposed by the d-stereochemistry of the residues at positions P1 and P1′.
format Online
Article
Text
id pubmed-3311629
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33116292012-03-28 Rational Design and Characterization of D-Phe-Pro-D-Arg-Derived Direct Thrombin Inhibitors Figueiredo, Ana C. Clement, Cristina C. Zakia, Sheuli Gingold, Julian Philipp, Manfred Pereira, Pedro J. B. PLoS One Research Article The tremendous social and economic impact of thrombotic disorders, together with the considerable risks associated to the currently available therapies, prompt for the development of more efficient and safer anticoagulants. Novel peptide-based thrombin inhibitors were identified using in silico structure-based design and further validated in vitro. The best candidate compounds contained both l- and d-amino acids, with the general sequence d-Phe(P3)-Pro(P2)-d-Arg(P1)-P1′-CONH(2). The P1′ position was scanned with l- and d-isomers of natural or unnatural amino acids, covering the major chemical classes. The most potent non-covalent and proteolysis-resistant inhibitors contain small hydrophobic or polar amino acids (Gly, Ala, Ser, Cys, Thr) at the P1′ position. The lead tetrapeptide, d-Phe-Pro-d-Arg-d-Thr-CONH(2), competitively inhibits α-thrombin's cleavage of the S2238 chromogenic substrate with a K(i) of 0.92 µM. In order to understand the molecular details of their inhibitory action, the three-dimensional structure of three peptides (with P1′ l-isoleucine (fPrI), l-cysteine (fPrC) or d-threonine (fPrt)) in complex with human α-thrombin were determined by X-ray crystallography. All the inhibitors bind in a substrate-like orientation to the active site of the enzyme. The contacts established between the d-Arg residue in position P1 and thrombin are similar to those observed for the l-isomer in other substrates and inhibitors. However, fPrC and fPrt disrupt the active site His57-Ser195 hydrogen bond, while the combination of a P1 d-Arg and a bulkier P1′ residue in fPrI induce an unfavorable geometry for the nucleophilic attack of the scissile bond by the catalytic serine. The experimental models explain the observed relative potency of the inhibitors, as well as their stability to proteolysis. Moreover, the newly identified direct thrombin inhibitors provide a novel pharmacophore platform for developing antithrombotic agents by exploring the conformational constrains imposed by the d-stereochemistry of the residues at positions P1 and P1′. Public Library of Science 2012-03-23 /pmc/articles/PMC3311629/ /pubmed/22457833 http://dx.doi.org/10.1371/journal.pone.0034354 Text en Figueiredo et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Figueiredo, Ana C.
Clement, Cristina C.
Zakia, Sheuli
Gingold, Julian
Philipp, Manfred
Pereira, Pedro J. B.
Rational Design and Characterization of D-Phe-Pro-D-Arg-Derived Direct Thrombin Inhibitors
title Rational Design and Characterization of D-Phe-Pro-D-Arg-Derived Direct Thrombin Inhibitors
title_full Rational Design and Characterization of D-Phe-Pro-D-Arg-Derived Direct Thrombin Inhibitors
title_fullStr Rational Design and Characterization of D-Phe-Pro-D-Arg-Derived Direct Thrombin Inhibitors
title_full_unstemmed Rational Design and Characterization of D-Phe-Pro-D-Arg-Derived Direct Thrombin Inhibitors
title_short Rational Design and Characterization of D-Phe-Pro-D-Arg-Derived Direct Thrombin Inhibitors
title_sort rational design and characterization of d-phe-pro-d-arg-derived direct thrombin inhibitors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311629/
https://www.ncbi.nlm.nih.gov/pubmed/22457833
http://dx.doi.org/10.1371/journal.pone.0034354
work_keys_str_mv AT figueiredoanac rationaldesignandcharacterizationofdpheprodargderiveddirectthrombininhibitors
AT clementcristinac rationaldesignandcharacterizationofdpheprodargderiveddirectthrombininhibitors
AT zakiasheuli rationaldesignandcharacterizationofdpheprodargderiveddirectthrombininhibitors
AT gingoldjulian rationaldesignandcharacterizationofdpheprodargderiveddirectthrombininhibitors
AT philippmanfred rationaldesignandcharacterizationofdpheprodargderiveddirectthrombininhibitors
AT pereirapedrojb rationaldesignandcharacterizationofdpheprodargderiveddirectthrombininhibitors